Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Back

EHRA Premium Access

Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Session: Moderated ePosters 11: AF: stroke and anticoagulation

Topic: Rhythm Control, Cardioversion

Speaker: Doctor W. McIntyre (Hamilton, CA)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Doctor William McIntyre

Population Health Research Institute, Hamilton (Canada)

3 presentations

0 follower

5 more presentations in this session

Diabetes mellitus, time in the therapeutic range and adverse outcomes in patients with atrial fibrillation: insights from the AFFIRM study

Speaker: Doctor M. Proietti (Milan, IT)

Access

Abstract

Slides

Different obesity paradox of ischemic stroke without and with atrial fibrillation

Speaker: Assistant Professor Y. Baek (Incheon, KR)

Access

Abstract

Usefulness of CHADS2-VASc score in predicting stroke in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Doctor A. Berkovitch (Ramat Gan, IL)

Access

Abstract

Slides

Prediction of Thromboembolic Events in Anticoagulated Patients with Atrial Fibrillation: Comparison of CHA2DS2-VASc and GARFIELD-AF Stroke Risk Scores

Speaker: Doctor M. Proietti (Milan, IT)

Access

Abstract

Slides

Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure

Speaker: Doctor S. Bordignon (Frankfurt, DE)

Access

Abstract

Slides

Access the full session

Moderated ePosters 11: AF: stroke and anticoagulation

Speakers: Doctor W. McIntyre, Doctor M. Proietti, Assistant Professor Y. Baek, Doctor A. Berkovitch, Doctor M. Proietti...

Access

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources